Prescription

MRD / Regn No.

: 20260000612

Date

: 02/07/2026

Patient Name

: Jiten Nandi

Age & Gender

: 51 Yrs. / Male

Contact No.

: 7384736324

UHID

:

Ht / Wt / BMI

: 159 / 66 / 26.11

BP S / BP D

: 110 / 70

Allergies

: NKA

Referred By

:

Problem List	:	TYPE 2 DM (02/Jul/2021) \| F0S2 MASLD (02/Jul/2026) \|
Subjective	:	DM FOR 5 YEARS,DYSLIPIDEMIA
Objective	:	NONE
Analysis	:	TYPE 2 DM,CDR ON OCT > 0.3,S2F0 NAFLD
Plan	:	START GLP1RA SGLT2I,SEE ME IN 1 MONTH
Salient Investigations	:	ESR: 7 mm/hour \| FASTING PLASMA GLUCOSE (FPG): 162 mg/dL \| GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.8 % \| POST PRANDIAL GLUCOSE (2HPP): 349 mg/dL \| HEMOGLOBIN: 13.5 g/dL \| MCH: 29 pg \| MCHC: 34 gm % \| MCV: 86 fl \| PCV: 40 % \| PLATELETS: 123 thou cells/ ul \| RBC COUNT: 4.61 million/ul \| TOTAL COUNT WBC: 6.81 Cells/cmm \| TSH : 2.540 mIU/L \| UREA: 23 mg/dL \| CREATININE: 0.85 mg/dL \| 24 H URINARY CALCIUM: 4.2 mg/24 hours \| HDL HIGH DENSITY LIPOPROTEIN: 38 mg/dL \| LDL LOW DENSITY LIPOPROTEIN: 66 mg/dL \| TGL TRIGLYCERIDE: 263 mg/dL \| TOTAL CHO/HDL RATIO: 3.5 \| TOTAL CHOLESTEROL: 132 mg/dl \| VLDL: 53 mg/dl \| A\G RATIO: 1.94 g/dl \| ALBUMIN (SERUM): 4.84 g/dL \| ALKALINE PHOSPHOTASE: 69 IU/L \| DIRECT BILIRUBIN: 0.76 mg/dl \| GAMMA GLUTAMYL TRANSFERASE (GGT): 33 U/L \| GLOBULIN: 2.50 g/dl \| INDIRECT BILIRUBIN: 1.74 \| SGOT (AST): 40 U/L \| SGPT (ALT): 67 IU/L \| TOTAL BILIRUBIN: 2.50 mg/dL \| TOTAL PROTEIN: 7.34 g/dl \| BICARBONATE: 25 meq/L \| CHLORIDE: 100 meq/L \| POTASSIUM: 4.0 meQ/L \| SODIUM: 137 meq/L \| CALCIUM: 9.4 mg/DL \| MICROALBUMIN CREATININE RATIO: 2.96 mcg/mg \| CUP DISC RATIO L: 0.18 \| CUP DISK RATIO R: 0.20 \| ABI LEFT: 1.07 \| ABI RIGHT: 1.05 \| E / E PRIME: 11 \| EJECTION FRACTION: 60 % \| EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 \| FIB4: 2.03 \| EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 \| FIB4: 2.03 \| EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 \| FIB4: 2.03 \| EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 \| EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 \| EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 \| FIB4: 2.03 \| FIB4: 2.03 \| LIVER CAP: 271 dB/M \| LIVER ELASTICITY: 4.8 kPA \| LIVER METAVIR SCORE: S2 \| LIVER STEATOSIS SCORE: F0

S#	Generic (Trade) Name	Route	Dosage	Usage	Duration
1	INJECTION SEMAGLUTIDE SEMALIX 0.25 MG Medicine For DIABETES OBESITY MASLD CAD	SQ	ONCE A WEEK	AS DIRECTED NO RELATION TO FOOD	TILL NEXT VISIT
	MAY CAUSE NAUSEA VOMITING OR EYE DISTURBANCE

2	SGLT2I EMPAGLIFLOZIN 10 MG JARDIANCE Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION	PO	1-0-0	BEFORE FOOD	TILL NEXT VISIT
	MAY CAUSE GENITOURINARY INFECTIONS

3	ROSUVASTATIN 10 MG ROSEDAY 10 MG Medicine For CHOLESTEROL	PO	0-0-1	AT BEDTIME	TILL NEXT VISIT
	MAY CAUSE FATIGUE AND MUSCLE PAIN

Refill : 0 / Substitution:

Education

:

Next Visit

: 01/Aug/2026

Tests Suggested For Next Visit

: FBS 2HPP SMBG